Laxmi Dental Quarterly Results for Trading Insights
In Sept 2025, Laxmi Dental (LAXMIDENTL) reported revenue ₹73 Cr and net profit ₹9 Cr — revenue +28.1% YoY. For annual financials, live price and key ratios, visit LAXMIDENTL company profile.
LAXMIDENTL Quarterly Results — Revenue, Profit & EPS Highlights
Laxmi Dental latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with LAXMIDENTL intrinsic value calculation to assess whether the stock is under or overvalued.
- Revenue of ₹73 Cr in Sept 2025 (+15.9% vs Mar 2025, +28.1% vs Sept 2024)
- Net Profit of ₹9 Cr in Sept 2025 (+125.0% vs Mar 2025, +50.0% vs Sept 2024)
- EBITDA of ₹12 Cr in Sept 2025 (+9.1% vs Mar 2025)
- Operating Margin of 14.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹1.59 in Sept 2025 (+101.3% vs Mar 2025)
Laxmi Dental Quarterly Results — Revenue, EBITDA, Net Profit & EPS
LAXMIDENTL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 73 | 63 | 66 | 66 | 57 | 15.9% | 28.1% |
| Net Profit (₹ Cr) | 9 | 4 | 8 | 2 | 6 | - | - |
| EBITDA (₹ Cr) | 12 | 11 | 12 | 1 | 9 | - | - |
| EPS (₹) | 1.59 | 0.79 | 1.53 | 0.37 | 2.12 | - | - |
| Operating Margin (%) | 14.0% | 15.0% | 17.0% | -1.0% | 14.0% | - | - |
LAXMIDENTL Share Price Trend — 1-Year Movement Across Quarterly Results
Laxmi Dental 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse LAXMIDENTL shareholding pattern to track promoter, FII and institutional holdings.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
LAXMIDENTL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Laxmi Dental latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹415,924.72 Cr | 1778.7 | 14,875 | 3,125 | +10.8% | - | 21.0% | 136.8 |
|
Divis Laboratories
Sept 2025 |
₹171,625.44 Cr | 6534.0 | 2,860 | 689 | +7.1% | - | 24.1% | 251.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹139,344.76 Cr | 4231.5 | 3,219 | 591 | +11.3% | - | 18.4% | 241.2 |
|
Dr Reddys Laborator…
Sept 2025 |
₹109,930.83 Cr | 1329.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 82.2 |
|
Lupin
Sept 2025 |
₹104,941.69 Cr | 2311.4 | 6,921 | 1,485 | +23.2% | - | 21.5% | 71.4 |
All amounts in ₹ Crores